Stifel's Paul Matteis joins BiotechTV for Analyst Thursdays
- blonca9
- Nov 9, 2023
- 1 min read
Paul Matteis comments on Biogen and Vertex earnings, discusses recent news on BioMarin and Sage, and highlights Xenon, Neumora, Karuna, Cerevel, and others.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page